Smith
& Nephew will make more of its artificial hips and knees in low-cost
countries such as China to reduce a cost burden that pushed third-quarter
profits down by almost a tenth.
Shares in Smith & Nephew fell as much as
7.5 per cent after trading margins at the FTSE 100 company’s orthopaedics
division fell more than expected, from 22.2 per cent a year ago to 15.6 per
cent.
Olivier Bohuon, who became chief executive
earlier this year, said he was “disappointed” with the performance at the
division as he unveiled plans to cut costs by at least $150m a year across the
group.
Smith & Nephew conducts most of its
manufacturing in the US and western Europe and less than a fifth in low-cost
locations. But the group said it was reviewing the “best configuration of our
manufacturing portfolio” in the face of “persistent pricing pressures in our
established markets”.
As well as increasing the proportion of
sourcing from emerging markets, Smith & Nephew also plans to shake up its
product offerings in them. “We have not had the right portfolio,” Mr Bohuon
said of its emerging markets operations. “We have been offering too many
high-tech products and discounting them, so we are losing margin.”
The group wants to offer cheaper,
lower-specification products in middle-income countries as it gears up to
increase annual sales from emerging markets by the middle of the decade.
Other efficiency measures include scrapping a
number of senior European posts.
Alistair Gray and Andrew Jack
The Financial Times
Business & Investment Opportunities
YourVietnamExpert is a division of Saigon Business Corporation Pte Ltd, Incorporated in Singapore since 1994. As Your Business Companion, we propose a range of services in Consulting, Investment and Management, focusing three main economic sectors: International PR; Healthcare & Wellness;and Tourism & Hospitality. We also propose Higher Education, as a bridge between educational structures and industries, by supporting international programs. Sign up with twitter to get news updates with @SaigonBusinessC. Thanks.
No comments:
Post a Comment